Top Markets
#1 Fabric Protocol Fabric Protocol +32.06%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.94%
#3 Tutorial Tutorial +31.67%
#4 Bitcoin Cash Bitcoin Cash +31.12%
#5 GALA GALA +30.99%
#6 Audiera Audiera +30.55%
#7 Zora Zora +26.33%
#8 GoPlus Security GoPlus Security +26.04%
#9 Arowana Arowana +25.32%
#10 Talus Network Talus Network +24.98%
Coin of the day
Fabric Protocol Fabric Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang in Aktien #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aktienkurs
$0.78611575
Marktkapitalisierung
$60.45M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Kategorie

Healthcare
Kursverlauf für Lytix Biopharma AS (LYTIX)
Höchster Schlusskurs: $0.83 am 2026-08-01

Niedrigster Schlusskurs: $1.84 am 2021-06-01
Kursverlauf der Aktie von Lytix Biopharma AS von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $546.40 37.47%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 57.85%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.43 435.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH